期刊文献+

低钙透析对尿毒症患者甲状旁腺功能的影响 被引量:9

Effect of low calcium dialysate on parathyroid hormone secretion in maintenance hemodialysis patients
在线阅读 下载PDF
导出
摘要 目的 探讨低钙透析对慢性肾衰竭维持性血液透析患者甲状旁腺功能的影响。方法 前瞻性观察 5 8例维持性血液透析患者在单次高钙透析 (透析液钙 1.75mmol/L)、单次低钙透析 (透析液钙1.2 5mmol/L)前后及持续低钙透析 1个月后 (2~ 3次 /周 ,4小时 /次 )血钙及甲状旁腺激素水平的变化。结果①单次高钙透析 4小时后血钙水平明显升高 [(2 .18± 0 .15 )mmol/Lvs (2 .35± 0 .0 8)mmol/L],iPTH水平没有明显变化 [(191.4 1± 10 8.19)ng/Lvs (190 .4 1± 93.5 0 )ng/L]。②单次低钙透析 4小时后血钙水平没有明显变化 [(2 .2 0± 0 .13)mmol/Lvs (2 .2 2± 0 .17)mmol/L) ],但iPTH显著升高 [(186 .0 5± 10 6 .2 4 )ng/Lvs (2 10 .0 4± 113.4 6 )ng/L) ]。③持续低钙透析 1月后血钙水平没有变化 [(2 .2 0± 0 .13)mmol/Lvs(2 .2 3± 0 .11)mmol/L],iPTH有明显升高 [(186 .0 5± 10 6 .2 4 )ng/Lvs (2 2 9.98± 12 0 .2 0 )ng/L]。结论 低钙透析会刺激甲状旁腺激素的分泌 ,加剧尿毒症患者的继发性甲状旁腺功能亢进。 Objective To investigate the effect of low calcium dialysate on iPTH levels of maintenance hemodialysis patients. Methods Fifty-eight chronic HD patients(male/female 37/21, mean age (47.2±10.4) years, mean HD periods: (3.7±1.2) years who had been dialyzed with 1.75mmol/L Ca ++ dialysate were studied. All patients were transferred to the low calcium(1.25mmol/L) dialysate. The serum level of Ca ++ , Pi and iPTH were measured after a single HD session and after one month low-calcium hemodialysis. Results ① The iPTH had no change after one session of high calcium dialysis despite that serum Ca ++ level increased significantly from [(2.18±0.15)mmol/L to (2.35±0.08)mmol/L];② Although serum Ca ++ did not change, iPTH increased significantly after a single low-calcium dialysis session [(186.05±106.24)ng/L vs (210.04±113.46)ng/L)]; ③After one month of low-Ca ++ hemodialysis, though serum Ca ++ had no change, iPTH increased significantly [(186.05±106.24)ng/L vs (229.98±120.20)ng/L]. Conclusions Low calcium dialysate stimulates the secretion of parathyroid hormone in maintenance hemodialysis patients.
出处 《中国血液净化》 2004年第2期85-86,116,共3页 Chinese Journal of Blood Purification
关键词 低钙透析 尿毒症 甲状旁腺功能 甲状旁腺素 血液透析 Hemodialysis Low-calcium-dialysate IPTH
  • 相关文献

参考文献11

  • 1[1]Holgado R, Hairre h, Ross D, et al. Effects of low calcium dialysate on parathyroid hormone secretion in diabetic patients on maintenance hemodialysis. J Bone miner Res, 2000,15;927-35
  • 2[2]Talmage RV, Roycroft JH, Anderson JJB. morphological considerations in new concept of calcium transport in bone. Am J Anat, 1975,129:467-476
  • 3[3]Fernandez E, Borras M, Pais B, et al. Low-cacium dialysis stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism. J Am Soc nephrol, 1995,6:132-135
  • 4[4]Sherrard DJ, herca G, Pei Y, et al. The spectrum of bone disease in end-stage renal failure: An evolving disorder. Kidney int, 1993,43:436-442
  • 5[5]Yokoyama K, Shigematus T, Kagami S, et al. Vitamin D receptor gene polymorphism detected by digestion with Apo I influences the parathyroid response to extracellular calcium in Japanese chronic dialysis patients. Nephron, 2001, Nov 89(3) 315-320
  • 6[6]Fabrizi F, Bacchini G, Di Filippo S. Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid function. Nephron,1996, 72(4) 530-535
  • 7[7]Goodman WG, Goldin J, Kuizon BD, et al. cornary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J med, 2000,342:1478-1483
  • 8[8]Chertow GM, Burke SK, Dillon MA, et al. Lond-term effects of Senelamer hydrochloride on calcium × phosphate product and lipid profile of haemodialysis patients. Nephrol dial Transplant,1999,14:2907-2914
  • 9[9]Slatopolsky EA, Broke SK, Dillon MA. renaGell,a nonabsorbed calcium- and alminumfree phosphate binder, lowers serum phosphorus and parathyroid hormone: the RenaGell Study Group. Kindey int, 1999,55:299-307
  • 10[10]uncan R, Cochrane T, Bhalla C, et al.Low calcium dialysate and hyperparathyroidism. Perit dial ant, 1996, 16 suppl 1:s499-502

同被引文献59

引证文献9

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部